InsidersTradesSigma
Follow the 광동제약 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Food & Beverage sector, 광동제약 has recorded 6 reports. Market capitalisation: €300bn. The latest transaction was disclosed on 30 June 2026 (Other). Among the most active insiders: 최성원. All data is openly available.
6
Insider Decl.
n/a
Thresholds
€81,964
3 ops.
Buy Volume
n/a
1 ops.
Sell Volume
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,120 of 29,062 companies
50.9
score / 100
Value74
Quality28
FCF yld18%
Earn yld6.6%
EV/EBITDA10.3x
ROE3.5%
Gross mgn18%
Net mgn1.3%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 June 2026
Declarations6 total
6 of 6 declarations
关于 광동제약
광동제약是一家韩国公司，专门从事药品和保健产品的制造。该公司在XKRX证券交易所上市。